After Hours Summary: UAL +5.8%, HWC +2.6% higher on earnings; ALVO +3.7% as FDA approves Selarsdi injection; JBHT -5.4% lower on earnings
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: UAL +5.8%, HWC +2.6%, OMC +0.6%
Companies trading higher in after hours in reaction to news: ALVO +3.7% (FDA approves Selarsdi injection as a biosimilar to Stelara), MESO +3.4% (files for 5.8 mln ADS offering by selling shareholders), ALK +2.9% (in sympathy with UAL earnings), CDNA +2.2% (names new CEO), AAL +1.8% (in sympathy with UAL earnings), DAL +1.5% (in sympathy with UAL earnings), JBLU +1.2% (in sympathy with UAL earnings), TCRX +1.1% (commences $125 mln public offering; also provides clinical pipeline update), LUV +0.9% (in sympathy with UAL earnings), OMGA +0.4% (CFO to step down), BIP +0.2% (files for 170 mln limited partnership units by selling unitholder)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: JBHT -5.4%, GAU -1.4%, FULT -0.8%, IBKR -0.3% (also increases dividend by 150%)
Companies trading lower in after hours in reaction to news: APG -2.9% (commences 11 mln share offering), ITCI -1.7% (commences $500 mln stock offering; also files mixed shelf securities offering), TTWO -1.3% (5% workforce reduction as part of broader restructuring plan), RYAM -0.7% (ships first production of 2G bioethanol from its Tartas plant), UHT -0.5% (files $100 mln mixed shelf securities offering), ALG -0.3% (unionized workers to strike after failing to reach labor agreement), MEG -0.1% (3 mln share offering), TEVA -0.1% (FDA approves Selarsdi injection as a biosimilar to Stelara)